Research Insights

• Sponsor: National Institutes of Health (NIH)
• Internal Deadline: April 28, 2020
• Sponsor LOI Deadline: July 28, 2020
• Sponsor Deadline: August 28, 2020
• Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-20-007.html

Summary

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from single institutions or consortia of institutions to participate in the Asthma and Allergic Diseases Cooperative Research Centers (AADCRC) program. The program will support centers that integrate clinical and translational research to conduct studies on the mechanisms underlying the onset and progression of diseases of interest, including asthma, rhinitis (allergic and non-allergic), chronic rhinosinusitis, atopic dermatitis, food allergy, and drug allergy. The overarching goal of the program is to improve the understanding of the pathogenesis of these conditions and to provide a rational foundation for new, effective treatments and prevention strategies.   

Please read the full program announcement before preparing your internal application.

Award Amount

• Application budgets are limited to $900,000 in direct costs per year, excluding the IOF budget, and need to reflect the actual needs of the proposed project. 
• The maximum project period is 5 years. 

Eligibility

• Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for Note that the multiple PD(s)/PI(s) option may be used only for the Overall Program. Projects are limited to a single project lead per project and a single core lead per core within the multi-component application.
• An investigator can serve as a PD/PI on only one AADCRC award or application. This includes all PD(s)/PI(s) of a multiple-PD/PI application
• NIH support.

Selection Criteria

• Detailed application review criteria can be found here.

Limitation Details

An Institution may submit one proposal. 

If you are interested in submitting for this program, you must first submit an internal application to limsub@uga.eduaccording to the required instructions below.

Internal Applications must include the following:

• A cover page listing
  • The name of this funding opportunity and title of your proposal
  • Your name, UGA position, home department, email, and UGA contact information
  • Collaborator names, positions, and institutions (if any)
  • Indicate whether or not you have submitted to this program in the past. If so, please provide a copy of the review at the end of the internal application.
• A (maximum two-page) proposal summary that addresses the program’s specific selection criteria.
• One paragraph describing why this proposal should be UGA’s submission (i.e., why it will be the most competitive for this program)
• A two-page Curriculum vitae

Internal Selection

Limited Submission announcements often generate multiple competing proposals.  UGA reviewers judge proposals as they would in any peer review process, so PIs are urged to put their best foot forward.  Along with typical criteria, reviewers will evaluate internal proposals based on their fit with the sponsor’s articulated goals and criteria. 

Internal Submission Instructions

The above internal application materials should be submitted via email as a single .PDF file to limsub@uga.edu by the internal deadline listed above. 

Questions?

Please submit questions regarding the internal competition to limsub@uga.edu.

For questions directly related to this program, please contact the following program officers:

Gang Dong, MD, PhD
Telephone: 240-627-3508 
Email: gdong@niaid.nih.gov 

---

View our calendar for all Current and Closed Limited Submissions.
Subscribe to our listerv to receive weekly internal competition announcements.
What is a Limited Submission?